Trial intelligence / Profile preview

Real-World Study of Onradivir Tablets vs Baloxavir in Influenza A Infection

ChiCTR2600126666Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of anlatrelvir and baloxavir marboxil in Influenza A infection (3 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Time to alleviation of influenza symptoms (TTAS). Planned start Jun 2026; status: not yet recruiting.

02

Drugs

anlatrelvirbaloxavir marboxil
03

Conditions

Influenza A infection

Beyond the preview

Go deeper on ChiCTR2600126666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600126666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call